| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |